Form 8-K - Current report:
SEC Accession No. 0001615774-17-003764
Filing Date
2017-07-24
Accepted
2017-07-24 07:39:41
Documents
4
Period of Report
2017-07-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K s106882_8k.htm 8-K 30560
2 EXHIBIT 99.1 s106882_ex99-1.htm EX-99.1 13525
3 GRAPHIC img001_v1.jpg GRAPHIC 11439
4 GRAPHIC img002_v1.jpg GRAPHIC 10835
  Complete submission text file 0001615774-17-003764.txt   76336
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 17977544
SIC: 2834 Pharmaceutical Preparations